Details for New Drug Application (NDA): 219044
✉ Email this page to a colleague
The generic ingredient in BISOPROLOL FUMARATE is bisoprolol fumarate; hydrochlorothiazide. There are twelve drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the bisoprolol fumarate; hydrochlorothiazide profile page.
Summary for 219044
| Tradename: | BISOPROLOL FUMARATE |
| Applicant: | Unique Pharm |
| Ingredient: | bisoprolol fumarate |
| Patents: | 0 |
Pharmacology for NDA: 219044
| Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for 219044
Suppliers and Packaging for NDA: 219044
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BISOPROLOL FUMARATE | bisoprolol fumarate | TABLET;ORAL | 219044 | ANDA | Rising Pharma Holdings, Inc. | 64980-709 | 64980-709-01 | 100 TABLET, FILM COATED in 1 BOTTLE (64980-709-01) |
| BISOPROLOL FUMARATE | bisoprolol fumarate | TABLET;ORAL | 219044 | ANDA | Rising Pharma Holdings, Inc. | 64980-709 | 64980-709-03 | 30 TABLET, FILM COATED in 1 BOTTLE (64980-709-03) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Apr 16, 2025 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Apr 16, 2025 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
